Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia with Venetoclax and Azacitidine

by Chyla, B., Dail, M., DiNardo, C.D, Döhner, H., Fracchiolla, N.S, Garcia, J.S, Illes, A., Jang, J.H, Jonas, B.A, Ozcan, M., Potluri, J., Pratz, K.W, Pullarkat, V., Recher, C., Schuh, A.C, Thirman, M.J, Vorobyev, V., Yamamoto, K., Yeh, S.-P, Zhou, Y.
Published 2022